Genfit (OTCMKTS:GNFTF) Stock Price Down 4.1% – Here’s Why

Genfit S.A. (OTCMKTS:GNFTF)’s share price was down 4.1% during trading on Wednesday . The stock traded as low as $10.43 and last traded at $10.43. Approximately 700 shares were traded during trading, an increase of 19% from the average daily volume of 590 shares. The stock had previously closed at $10.88.

Genfit Price Performance

The business has a 50-day simple moving average of $8.47 and a two-hundred day simple moving average of $5.71.

Genfit Company Profile

Genfit is a clinical?stage biopharmaceutical company headquartered in Lille, France, specializing in the development of innovative therapies and diagnostics for liver and metabolic diseases. The company’s research and development efforts are primarily focused on non?alcoholic steatohepatitis (NASH), a progressive liver disorder with significant unmet medical needs. Genfit’s lead therapeutic candidate, elafibranor, is designed to target key pathways involved in inflammation, fibrosis and lipid metabolism, positioning it as a potential treatment for patients with NASH and associated metabolic complications.

In addition to its therapeutic pipeline, Genfit has established a diagnostic arm centered on NIS4®, a proprietary blood?based test that leverages transcriptomic biomarkers to enable earlier and more accurate detection of liver fibrosis in patients at risk for NASH.